DANESE, SILVIO
 Distribuzione geografica
Continente #
EU - Europa 15.142
AS - Asia 14.698
NA - Nord America 7.605
SA - Sud America 5.522
AF - Africa 432
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 43.445
Nazione #
RU - Federazione Russa 9.212
US - Stati Uniti d'America 7.146
SG - Singapore 5.065
BR - Brasile 4.588
CN - Cina 3.997
HK - Hong Kong 2.275
VN - Vietnam 1.778
SE - Svezia 1.488
IT - Italia 1.052
FR - Francia 850
DE - Germania 591
FI - Finlandia 426
AR - Argentina 361
GB - Regno Unito 353
RO - Romania 292
IN - India 251
BD - Bangladesh 208
ID - Indonesia 198
CA - Canada 190
AT - Austria 176
EC - Ecuador 166
NL - Olanda 162
JP - Giappone 155
MX - Messico 154
ZA - Sudafrica 148
IQ - Iraq 118
TR - Turchia 117
CO - Colombia 110
ES - Italia 94
PY - Paraguay 90
PL - Polonia 89
CZ - Repubblica Ceca 84
PK - Pakistan 71
MA - Marocco 67
UZ - Uzbekistan 66
VE - Venezuela 64
UA - Ucraina 61
EG - Egitto 57
SA - Arabia Saudita 55
IE - Irlanda 53
CL - Cile 46
PE - Perù 42
UY - Uruguay 42
TN - Tunisia 38
DZ - Algeria 32
AE - Emirati Arabi Uniti 30
AU - Australia 28
JO - Giordania 28
AZ - Azerbaigian 27
IL - Israele 27
KE - Kenya 25
DO - Repubblica Dominicana 23
PH - Filippine 23
IR - Iran 21
NP - Nepal 21
KZ - Kazakistan 18
LT - Lituania 18
MY - Malesia 18
PT - Portogallo 18
TW - Taiwan 18
OM - Oman 17
BE - Belgio 16
TT - Trinidad e Tobago 16
AL - Albania 14
KR - Corea 14
PA - Panama 14
HN - Honduras 13
KW - Kuwait 13
RS - Serbia 13
BG - Bulgaria 12
BH - Bahrain 12
SN - Senegal 12
CH - Svizzera 10
ET - Etiopia 10
LB - Libano 10
BO - Bolivia 9
EU - Europa 9
GR - Grecia 9
JM - Giamaica 9
CI - Costa d'Avorio 8
GT - Guatemala 8
NI - Nicaragua 8
BY - Bielorussia 7
CR - Costa Rica 7
NG - Nigeria 6
PS - Palestinian Territory 6
SI - Slovenia 6
HU - Ungheria 5
KG - Kirghizistan 5
LV - Lettonia 5
MD - Moldavia 5
QA - Qatar 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CD - Congo 4
CY - Cipro 4
DK - Danimarca 4
Totale 43.369
Città #
Moscow 2.266
Hong Kong 2.246
Singapore 2.129
Dallas 1.031
Ashburn 991
Hefei 841
Shanghai 790
San Jose 778
Lauterbourg 725
Lawrence 702
Princeton 700
Ho Chi Minh City 688
Beijing 482
Hanoi 378
São Paulo 364
New York 355
Helsinki 350
Milan 197
Los Angeles 196
Nuremberg 156
Rio de Janeiro 143
Orem 118
Munich 109
Santa Clara 104
Brasília 93
Tokyo 89
Belo Horizonte 88
Council Bluffs 88
Vienna 80
Campinas 75
Montreal 75
Olomouc 75
Da Nang 74
Haiphong 74
Curitiba 73
London 73
Frankfurt am Main 72
Porto Alegre 72
Rome 72
Warsaw 70
Johannesburg 64
Tashkent 61
Chicago 60
Salvador 58
Chennai 56
Guayaquil 54
Manchester 54
Biên Hòa 53
Quito 53
Guangzhou 52
Boardman 51
Baghdad 50
Brooklyn 50
Stockholm 50
Buenos Aires 48
Dublin 47
Poplar 47
Atlanta 46
Dhaka 44
Denver 43
Guarulhos 42
Lappeenranta 42
Amsterdam 41
Mexico City 40
Phoenix 39
Ribeirão Preto 37
Hải Dương 36
Seattle 36
Cape Town 35
Montevideo 35
Asunción 34
Mumbai 34
Goiânia 33
Houston 32
Manaus 32
Boston 31
Hangzhou 31
Jakarta 31
Lima 31
Recife 31
Santo André 31
Thái Bình 31
Ankara 29
Borås 29
Fortaleza 29
Istanbul 29
Sorocaba 29
Tianjin 29
Turku 28
Baku 27
Amman 26
Caxias do Sul 26
Buffalo 24
Juiz de Fora 24
Toronto 24
Uberlândia 24
Bologna 23
Delhi 23
Duque de Caxias 23
Falkenstein 23
Totale 20.357
Nome #
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 428
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 264
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 195
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 176
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 163
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 158
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 143
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 142
Crohn's disease 137
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 134
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 133
VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review 123
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 121
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 117
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 115
Inflammation and malnutrition in inflammatory bowel disease 114
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 111
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 109
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 108
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 105
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 103
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 103
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 102
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 101
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 101
New therapeutic avenues in ulcerative colitis: thinking out of the box 98
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 98
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 97
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 97
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 96
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 96
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 96
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 95
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 94
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 94
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 93
Inflammatory Bowel Disease and Colorectal Cancer 93
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 93
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 92
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 92
The Role of IL-23 Inhibitors in Crohn’s Disease 91
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 91
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 90
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 90
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 89
Endoscopic Management of Post-Esophagectomy Delayed Gastric Conduit Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures 89
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 88
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 88
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 87
Clinical Pathologic Challenge Saxophone Penis: Challenge 87
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 87
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 86
Ustekinumab as induction and maintenance therapy for Crohn's disease 86
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 86
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (R) (Cortiment (R)(MMX (R))) for active, mild-to-moderate ulcerative colitis 86
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 86
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 86
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 85
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 85
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 84
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 84
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 83
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 82
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 82
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 82
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 82
Correction to: Understanding the therapeutic toolkit for inflammatory bowel disease (Nature Reviews Gastroenterology & Hepatology, (2025), 22, 6, (371-394), 10.1038/s41575-024-01035-7) 82
A snapshot of the ongoing clinical research on COVID-19 82
Adalimumab in active ulcerative colitis: A "real-life" observational study 82
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 81
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies 81
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 80
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 80
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 80
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 79
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 79
Clinical Pathologic Challenge Saxophone Penis: Challenge 79
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting 79
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 79
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 79
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 79
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 79
Small Bowel Cancer in Crohn’s Disease 78
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 78
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 77
Biological agents for ulcerative colitis : Hypes and hopes 77
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 77
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 77
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 77
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 76
The Role of Fecal Microbiota Transplantation in IBD 75
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 75
Endoscopic vacuum therapy in the treatment of postesophagectomy leaks: Is intracavitary the way? 75
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 75
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 75
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 75
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 74
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response 74
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 74
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial 73
Totale 9.914
Categoria #
all - tutte 287.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 287.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/202510.277 1.159 43 133 88 80 659 1.838 1.057 1.983 1.802 653 782
2025/202628.735 2.473 2.248 2.300 4.520 2.224 841 2.412 2.146 8.381 1.190 0 0
Totale 44.467